Assignee: Yamanouchi Pharmaceutical Co., Ltd.

Location: Tokyo, JP
No. of patents: 319

«First «Previous1 2 3 4 5 6 7 8 Next»Last»

Number	Title	Issue Date
7989634	Melanocortin receptor agonists The present invention relates a compound of formula 1, and pharmaceutically acceptable salt, hydrate, solvate, or isomer thereof effective as agonist of melanocortin receptor, and an agonistic composition of melanocortin receptor comprising the same as active ingred...	08/02/2011
7794748	Stable oral solid drug composition This invention is aimed to provide a stabilized formulation of ramosetron or a pharmaceutically acceptable salt thereof under a temperature/humidity condition, especially at a low content and relates to a stable oral solid drug composition of ramosetron or a pharmac...	09/14/2010
7268150	2-cyano-4-fluoropyrrolidine derivative or its salt Provided is a compound having excellent dipeptidyl peptidase IV-inhibiting activity, and a remedy based on the activity for insulin-dependent diabetes (type 1 diabetes), especially for non insulin-dependent diabetes (type 2 diabetes), insulin-resistant disorders, an...	09/11/2007
7008640	Pharmaceutical composition for oral use with improved absorption The present invention presents a pharmaceutical composition for oral use with improved absorption, which comprises drug, aminoalkyl methacrylate copolymer E, and acidic substance and is obtained by bringing said 3 components together and uniformly mixing at least th...	03/07/2006
6960591	Propane-1,3-dione derivative Provided is a pharmaceutical composition containing a propane-1,3-dione derivative as the active ingredient, particularly a GnRH receptor antagonist. Also, provided is a propane-1,3-dione derivative having a GnRH antagonistic effect. ...	11/01/2005
6949543	Amide derivative The invention relates to a novel amide derivative which is an N-({[4-(substituted thiazol-4-yl)phenyl]carbamoyl}methyl)amide derivative having a characteristic in that an aryl or heteroaryl group as an aromatic ring group is directly substituted on the N atom of ami...	09/27/2005
6927233	5ht2 agonists for controlling IOP and treating glaucoma Compositions and methods for controlling intraocular pressure and treating glaucoma using 1-(2-aminopropyl)-indazol-6-ol are disclosed. ...	08/09/2005
6919372	Sustained release pharmaceutical compositions The present invention relates to sustained-release pharmaceutical compositions for ionic pharmaceutically active substances containing ionic compounds having opposite charges to those of ionic prostanoic acid derivatives and increasing hydrophobicity of the active s...	07/19/2005
6903125	Tetrahydro-2H-thiopyran-4-carboxamide derivative A pharmaceutical drug, particularly a novel compound useful for the prophylaxis or therapeutic treatment of various diseases involving infections with viruses of the Herpesviridae family, specifically various herpesvirus infections such as varicella (chicken pox) vi...	06/07/2005
6899899	Rapidly disintegrable pharmaceutical composition The present invention relates to a pharmaceutical composition useful for rapid disintegration, which comprises a sparingly soluble medicament held on a gel-forming water-soluble polymer as a solid dispersion, wherein it contains a salt substance that comprises an al...	05/31/2005
6878525	Peptide leukotriene receptor A cDNA encoding a novel LTC4 receptor has been isolated. Provision of the novel protein, an LTC4 receptor, enabled binding experiments using the LTC4. By screening for compounds that modulate LTC4 receptor activity based o...	04/12/2005
6872405	Quick-disintegrating tablet in buccal cavity and manufacturing method thereof The present invention relates to a quick-disintegrating tablet in the buccal cavity comprising a drug, a diluent, and a saccharide with a relatively lower melting point than the drug and the diluent, which is obtained by uniformly mixing the saccharide with a low me...	03/29/2005
6861070	Medicinal compositions for treating evacuatory insufficiency A therapeutic agent for voiding dysfunction associated with neurogenic bladder where said agent contains tamsulosin or a pharmaceutically acceptable salt thereof. ...	03/01/2005
6838457	Fused heteroaryl derivatives The present invention provides a pharmaceutical composition which is useful as a phosphatidylinositol 3 kinase (PI3K) inhibitor and an antitumor agent, and it provides a novel bicyclic or tricyclic fused heteroaryl derivative or a salt thereof which possesses an exc...	01/04/2005
6828101	Methods of screening for modifiers of potassium channel protein activity The present invention relates to a novel potassium channel protein expressed exclusively in the brain, a gene encoding this protein, a vector containing this gene, a host cell containing this vector, and so on. A typical method for obtaining the potassium cha...	12/07/2004
6808899	Polynucleotides encoding SREB3 receptor This invention belongs to the genetic engineering field, and provides novel G protein-coupled receptor family proteins SREB1, SREB2 and SREB3 expressed in the central nervous system, genes coding for these proteins, screening methods using these proteins and so on. ...	10/26/2004
6803054	Technical field The present invention relates to a quick disintegrating tablet in buccal cavity, comprising: a mixture, comprising a drug, a sugar (A), and an amorphous sugar (B), and after it is forming a tablet, it is humidified and dried. In particularly, the present invention r...	10/12/2004
6797706	Heterocyclecarboxamide derivative A nitrogen-containing six-membered heterocyclic compound having substituents —X—A—R3, —N(R1)-(Ph substituted by R2), and —CONH2, a salt thereof, a prodrug thereof, and a Syk inhibitor containing the same as an ac...	09/28/2004
6774131	Remedies for endothelin-induced diseases A pharmaceutical composition for therapeutically treating prostate cancer, the pharmaceutical composition containing N-[6-methoxy-5-(2-methoxyphenoxy)-2-(2-pyrimidinyl)-4-pyri midinyl]-2-phenylethenesulfoneamide or a pharmaceutically acceptable salt thereof as the e...	08/10/2004
6770641	Fused heteroaryl derivatives The present invention provides a pharmaceutical composition which is useful as a phosphatidylinositol 3 kinase (PI3K) inhibitor and an antitumor agent, and it provides a novel bicyclic or tricyclic fused heteroaryl derivative or a salt thereof which possesses an exc...	08/03/2004
6761895	Drug delivery system for averting pharmacokinetic drug interaction and method thereof The present invention is a system for averting undesirable pharmacokinetic drug interaction between a drug and concomitant drug(s), which consists of controlling the in vivo release time and/or release site of the drug and/or the concomitant drug. ...	07/13/2004
6740662	Naphthyridine derivatives 2-Oxo-1,2-dihydro-1,8-naphthyridine derivatives characterized by bearing a specific substituent, —X—R6, at the 3-position and a cyclic substituent, R5, at the 4-position; or salts thereof. The derivatives and the salts are useful as drugs, ...	05/25/2004
6727233	Medicinal compositions for treating osseous lesion in multiple myeloma Pharmaceutical compositions for treating bone lesions in multiple myeloma or pharmaceutical compositions for treating multiple myeloma which contain as an active ingredient a compound having both of an effect of suppressing bone resorption accompanying multiple myel...	04/27/2004
6716613	Metalloprotease having aggrecanase activity This invention provides a novel metalloprotease having an aggrecanase activity which causes joint diseases, a gene coding for this metalloprotease, a promoter of the above metalloprotease, a method for screening a drug with the use of the above metalloprotease and a...	04/06/2004
6706284	Bitterness-reduced oral pharmaceutical composition The invention relates to an oral pharmaceutical composition which has excellent drug release-controlling ability in the mouth even 5 to 10 minutes after its administration and also has excellent drug releasing ability in the digestive tract without using capsules. I...	03/16/2004
6699503	Hydrogel-forming sustained-release preparation The invention provides a hydrogen-type sustained-release preparation comprising (1) at least one drug, (2) an additive which insures a penetration of water into the core of the preparation and (3) a hydrogen-forming polymer, wherein said preparation is ca...	03/02/2004
6682718	Remedies for periodontosis The invention relates to an alveolar bone resorption inhibitor for use in topical injection by an alveolar mucosa injection method, which comprises a bisphosphonic acid derivative or a salt thereof as an active ingredient and to an alveolar bone resorptio...	01/27/2004
6673799	Cyanophenyl derivative This application relates to a piperazino-substituted novel cyanophenyl derivative in which a substituted carbamoyl or substituted sulfamoyl group having an aryl, heterocyclic or the like group that may have a substituent group is bonded to one nitrogen at...	01/06/2004
6670326	Depsipeptide compound This invention relates to a novel compound which has a cytotoxic activity and TGF-ଲ like activity for human cancer cells and is useful as an antitumor agent and to a pharmaceutical composition which contains the same....	12/30/2003
6664283	Pharmaceuticals for neurogenic pain This invention relates to pharmaceuticals for neuropathic pains comprising an mGluR1 receptor antagonist for systemic administration. Drugs efficacious in treating various neuropathic pain can be provided by the invention....	12/16/2003
6656492	Quick disintegrating tablet in buccal cavity and manufacturing method thereof The present invention pertains to a quick disintegrating tablet in buccal cavity, characterized in that drug-containing particles with a mean particle diameter of approximately 50~approximately 250 μm and an apparent specific gravity of approximately 0.5...	12/02/2003
6653320	Imidazopyridine derivatives The present invention relates to novel compounds having a phosphatidylinositol 3 kinase (PI3K) inhibiting activity which are useful as medicaments, more particularly as antitumor agent. Novel 3-(imidazo[1,2-a]pyridin-3-yl) derivatives or salts thereof exh...	11/25/2003
6642224	Diazepan derivatives or salts thereof To provide a compound which has an anticoagulation action based upon inhibition of activated blood coagulation factor X and is useful as an anticoagulant or an agent for prevention and treatment of diseases caused by thrombus or embolus. A diazepan deriva...	11/04/2003
6642264	Thiazolobenzoimidazole derivatives This invention relates to novel thiazolo[3,2-a]benzoimidazole derivatives represented by the following general formula (I). The compounds provided by the invention act specifically on metabotropic glutamate receptors and are used as medicaments. The inven...	11/04/2003
6608053	Fused heteroaryl derivatives The present invention provides a pharmaceutical composition which is useful as a phosphatidylinositol 3 kinase (PI3K) inhibitor and an antitumor agent, and it provides a novel bicyclic or tricyclic fused heteroaryl derivative or a salt thereof which posse...	08/19/2003
6589554	Tablets quickly disintegrating in the oral cavity and process for producing the same The present invention relates to a quick disintegrating tablet in buccal cavity, comprising: a mixture, comprising a drug, a sugar (A), and an amorphous sugar (B), and after it is forming a tablet, it is humidified and dried. In particularly, the present ...	07/08/2003
6555344	Polynucleotides encoding SRE B2 receptor This invention belongs to the genetic engineering field, and provides the novel G protein-coupled receptor family protein SREB2 expressed in the central nervous system, genes coding for the protein, screening methods using the protein and so on. As one of...	04/29/2003
6465009	Water soluble polymer-based rapidly dissolving tablets and production processes thereof The invention provides for novel compressed tablets capable of rapidly disintegrating in aqueous solutions, comprising at least one non-saccharide water soluble polymer, which are free of organic solvent residues, and methods of making such pharmaceutical...	10/15/2002
6436441	Hydrogel-forming sustained-release preparation The invention provides a hydrogel-type sustained-release preparation comprising (1) at least one drug, (2) an additive which insures a penetration of water into the core of the preparation and (3) a hydrogel-forming polymer, wherein said preparation is ca...	08/20/2002
6432963	Pyrimidine-5-carboxamide derivatives Pyrimidine-5-carboxamide derivatives represented by a general formula (I) or salts thereof ##STR1## [wherein each symbol has the following meaning; X: O, S, NR1, CO, NR1 CO, CONR1, C.dbd.N--OR1 or a bond, Y: a l...	08/13/2002

«First «Previous1 2 3 4 5 6 7 8 Next»Last»

PatentStorm

Bizarre Patents

PatentStorm News

Assignee: Yamanouchi Pharmaceutical Co., Ltd.